These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21720878)

  • 1. Growth hormone effect on body composition in Turner syndrome.
    Baldin AD; Fabbri T; Siviero-Miachon AA; Spinola-Castro AM; de Lemos-Marini SH; Baptista MT; D'Souza-Li LF; Maciel-Guerra AT; Guerra-Junior G
    Endocrine; 2011 Dec; 40(3):486-91. PubMed ID: 21720878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of growth hormone on body proportions in Turner syndrome compared with non-treated patients and normal women.
    Baldin AD; Fabbri T; Siviero-Miachon AA; Spinola-Castro AM; Lemos-Marini SH; Baptista MT; D'Souza-Li LF; Maciel-Guerra AT; Guerra G
    J Endocrinol Invest; 2010 Nov; 33(10):691-5. PubMed ID: 20354352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body proportions in patients with Turner syndrome on growth hormone treatment.
    Al ADK; Şükür NM; Özturan EK; Öztürk AP; Poyrazoğlu Ş; Baş F; Darendeliler FF
    Turk J Med Sci; 2023 Apr; 53(2):518-525. PubMed ID: 37476877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
    Esen I; Demirel F; Tepe D; Kara O; Koc N
    Growth Horm IGF Res; 2013 Oct; 23(5):196-9. PubMed ID: 23890535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of thyroid autoimmunity and the response to recombinant human growth hormone in Turner syndrome.
    Song Y; Yang H; Wang L; Gong F; Pan H; Zhu H
    J Pediatr Endocrinol Metab; 2021 Apr; 34(4):465-471. PubMed ID: 33662192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
    Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal Body Composition Increases the Cardiometabolic Risk in Adolescents and Young Adults With Turner Syndrome.
    Mondal S; Gargari P; Bose C; Garg MK; Chowdhury S; Mukhopadhyay S
    Endocr Pract; 2024 Mar; 30(3):259-269. PubMed ID: 38042448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
    Takeda A; Cooper K; Bird A; Baxter L; Frampton GK; Gospodarevskaya E; Welch K; Bryant J
    Health Technol Assess; 2010 Sep; 14(42):1-209, iii-iv. PubMed ID: 20849734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in body proportions and body fat content in GH-deficient and non-GH-deficient children during the first year of growth hormone treatment.
    Majcher A; Rumińska M; Witkowska-Sędek E; Paluchowska M; Krajewska M; Artemniak-Wojtowicz D; Pyrżak B
    Anthropol Anz; 2024 Jun; ():. PubMed ID: 38912850
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of long-term recombinant growth hormone therapy in children--the National Cooperative Growth Study, USA, 1985-1994.
    Root AW; Kemp SF; Rundle AC; Dana K; Attie KM
    J Pediatr Endocrinol Metab; 1998; 11(3):403-12. PubMed ID: 11517956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapy.
    Landin-Wilhelmsen K; Bryman I; Windh M; Wilhelmsen L
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):497-502. PubMed ID: 10583318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the influencing factors of recombinant human growth hormone effect in the children with Turner syndrome].
    Li J; Wu W; Liang Y; Luo XP
    Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):866-870. PubMed ID: 30392213
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychosocial functioning, self-perception and body image and their auxologic correlates in growth hormone and oestrogen-treated young adult women with Turner syndrome.
    Lagrou K; Froidecoeur C; Verlinde F; Craen M; De Schepper J; François I; Massa G;
    Horm Res; 2006; 66(6):277-84. PubMed ID: 16946621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic predictors of long-term response to growth hormone (GH) therapy in children with GH deficiency and Turner syndrome: the influence of a SOCS2 polymorphism.
    Braz AF; Costalonga EF; Trarbach EB; Scalco RC; Malaquias AC; Guerra-Junior G; Antonini SR; Mendonca BB; Arnhold IJ; Jorge AA
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1808-13. PubMed ID: 24905066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of growth hormone treatment on bone mineral density and body composition in girls with turner syndrome.
    Ari M; Bakalov VK; Hill S; Bondy CA
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4302-5. PubMed ID: 16940444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference values for body proportions and body composition in adult women with Ullrich-Turner syndrome.
    Gravholt CH; Weis Naeraa R
    Am J Med Genet; 1997 Nov; 72(4):403-8. PubMed ID: 9375721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interactive effect of GHR-exon 3 and -202 A/C IGFBP3 polymorphisms on rhGH responsiveness and treatment outcomes in patients with Turner syndrome.
    Braz AF; Costalonga EF; Montenegro LR; Trarbach EB; Antonini SR; Malaquias AC; Ramos ES; Mendonca BB; Arnhold IJ; Jorge AA
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E671-7. PubMed ID: 22278433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal disproportion in girls with Turner syndrome and longitudinal change with growth-promoting therapy.
    McVey LC; Fletcher A; Murtaza M; Donaldson M; Wong SC; Mason A
    Clin Endocrinol (Oxf); 2021 May; 94(5):797-803. PubMed ID: 33410185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is growth hormone treatment in children associated with weight gain?--longitudinal analysis of KIGS data.
    Reinehr T; Lindberg A; Koltowska-Häggström M; Ranke M
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):721-6. PubMed ID: 24750131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.